Mark Suter
8Patents
6h-index
16Co-inventors
56Inventor score
Filing activity: Dec 9, 1999 → Mar 14, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7097842B2 | Modified vaccinia virus ankara for the vaccination of neonates | Chemistry; Metallurgy | 40 | Expired |
| US7628980B2 | Modified vaccinia virus ankara for the vaccination of neonates | Chemistry; Metallurgy | 15 | Expired |
| US6573090B1 | Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors | Chemistry; Metallurgy | 14 | Expired |
| US7892533B2 | Modified vaccinia virus ankara for the vaccination of neonates | Chemistry; Metallurgy | 13 | Active |
| US8372622B2 | Modified vaccinia virus ankara for the vaccination of neonates | Chemistry; Metallurgy | 11 | Active |
| US7897156B2 | Modified vaccinia virus ankara for the vaccination of neonates | Emerging Cross-Sectional Technologies | 11 | Active |
| US9707291B2 | Single high dose of MVA induces a protective immune response in neonates and infants | Emerging Cross-Sectional Technologies | 0 | Active |
| US8859257B2 | Vaccinia virus mutants containing the major genomic deletions of MVA | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.